This 2-arm crossover study compared the relative bioavailability of two dovitinib ( TKI258 ) formulations [ anhydrate clinical service form ( CSF ) capsule and monohydrate final market image ( FMI ) tablet ; Arm 1 ] and determined the effect of food on dovitinib exposure ( Arm 2 ) .